Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats

BACKGROUND: Parasitic bronchopneumonia in domestic cats in Europe, which can manifest with moderate to severe clinical signs, is frequently caused by Troglostrongylus brevior. Data on epizootiological and clinical relevance of cat troglostrongylosis have been published in the last decade but treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Traversa, Donato, Raue, Katharina, Ringeisen, Hannah, Blazejak, Katrin, Bisterfeld, Katrin, Di Cesare, Angela, Colombo, Mariasole, Böhm, Claudia, Strube, Christina, Pollmeier, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862244/
https://www.ncbi.nlm.nih.gov/pubmed/35193656
http://dx.doi.org/10.1186/s13071-022-05185-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862244/
https://www.ncbi.nlm.nih.gov/pubmed/35193656
http://dx.doi.org/10.1186/s13071-022-05185-y

Ejemplares similares